Top 10 Medical Device VC Funds in Portugal

Last updated: Apr 2024 A list of 10 VC funds that invest in Medical device startups based in Portugal. We rank investors based on the number of investments they made in Medical device companies from Portugal. We update this investor list every month.

Top 10 Medical Device VC Funds in Portugal

Investor	Medical Device Portugal investments
Portugal Ventures	8
Bynd Venture Capital	4
Caixa Capital	3
Armilar Venture Partners	2
Brighteye Ventures	2
Beta Capital	1
EIT Health	1
Boule Diagnostics	1
Artesian VC	1
MSM	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme ParksMobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Pre-Seed
Portugal, United States, France

Portfolio highlights

Glooma — Glooma - We detect breast cancer at an early stage
Tonic App — Tonic App is a B2C2B digital health company building a professional ecosystem for medical doctors. Tonic App helps medical doctors to diagnose and treat their patients by curating, for them, in a single mobile platform, the best professional resources from peers, publishers, regulatory bodies, recruiters, providers & the industry.
Yon Living — Yon is creating a next-generation hotel brand based on shared living for people who can live and work from anywhere.

Bynd is a leading Iberian Venture Capital firm with focus on seed / early stage technology startups

Investment focus

Software, Health Care, SaaS
Seed, Series A, Funding Round
Portugal, Spain, United States

Portfolio highlights

Last.app — Last is a comprehensive restaurant software solution. Thanks to the use of new technologies, our platform offers unique solutions in the market, always with the aim of simplifying and optimizing the tasks of the team of any type of restaurant.
Trebellar — Trebellar provides advanced data analytics for building occupancy, energy efficiency, and climate optimization. Maximize your workplace productivity with our intelligent building solutions.
Incapto Coffee — Incapto Coffee offers the sale of the automatic coffee machine and a subscription system for coffee beans.

Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.

Investment focus

Software, Information Technology, SaaS
Seed, Series A, Funding Round
Portugal, United States, Spain

Portfolio highlights

HiJiffy — Increase direct bookings and upselling with HiJiffy's AI-powered communication solutions for hospitality.
Probely — Probely is a web application and API vulnerability scanner for agile teams. Automate Security Testing by adding Probely into your SDLC and CI/CD pipelines.
Infraspeak — Infraspeak is an Intelligent CMMS Software that brings outstanding flexibility, connectivity and intelligence to your operations.

Armilar Venture Partners is Portugal's leading venture capitalist. An independent VC with a 20-year-old history, a high-performance track record and an international footprint, Armilar is a deep-tech investor in ICT, HealthTech and CleanTech.

Investment focus

Software, Information Technology, Manufacturing
Series A, Seed, Funding Round
Portugal, United States, United Kingdom

Portfolio highlights

Bdeo — Bdeo provides a visual intelligence solution designed to change the way customers connect with insurance companies. Its platform enhances the customer journey beginning with underwriting and all the way through the time the claim is processed, also recognizing risks, damage, and providing assessments in real-time, allowing insurance companies todetect fraud or pay customers in the event a claim is approved.The company was founded in 2017 and is headquartered in Madrid, Spain.
Appentra — The first static code analyzer that increases the performance of C/C++ code. Write hardware-friendly code that runs faster on modern hardware.
KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!

Brighteye Ventures is the first and largest vertical EdTech Venture Capital firm in Europe. If you are an entrepreneur using technology to reinvent learning and education, we want to hear from you!

Investment focus

Education, Software, E-Learning
Seed, Series A, Pre-Seed
United Kingdom, Spain, France

Portfolio highlights

UpHill — Clinical algorithms, medical events, scientific evidence and a simulation software in one place
Shakers — We are Shakers and we are redefining the future of work. We connect companies and talent with a perfect match between personal and professional life through technology and methodology. We want to achieve a lifestyle in which work is synonymous with happiness so that you can work where, how and when you want. And thus be more productive and havebetter results in the projects in which you collaborate. Sounds good to you? You already have DNA Shakers, follow us !!
coachbetter — Football drills for kids, youth and pro teams in one platform. Coachbetter is your digital assistant coach. Manage football trainings, matches, teams and your club.

We support innovative tech ventures to unlock its potential by providing smart funding and hands-on advisory.

Investment focus

VoIP, Software, Wireless
Seed, Funding Round
Portugal

Portfolio highlights

Nonius Hospitality Technology — Integrated Cloud Based Hospitality Technology Solutions to Enhance Guest Experiences with Chromecast, TV, Wi-Fi, App, Signage and Voice.
Magnomics — Overview: Magnomics is a diagnostics, medical technology company committed to delivering a new generation of rapid, portable molecular diagnostic tests with applications in the human health, veterinary, and food industry markets. Affordable, disposable diagnostic cartridges will be produced in large scale and shipped via global distributors. Theteam behind the company has world class experience in biotechnology, electronics and physics, with a proven track record in managing start-ups. Magnomics has a Letter of Intent from a leading dairy company and won the 2015 Kansas City Animal Health Investment Forum innovation award, as well as the Ag Biotech Entrepreneurial Showcase award in North Carolina in 2016. €1.6M in seed financing have been raised through grants and investments. Magnomics is seeking €1.5M to conclude the prototyping of its first product in the animal health space. Technology: Magnomics technology stands on four patent families, with more in the pipeline, and has been published over twenty times in prestigious scientific journals. Magnomics provides a portable and affordable PCR device that requires no training to operate. The product integrates sample preparation, amplification and DNA detection within a single cartridge using microfluidics, making use of a novel magnetoresistive DNA sensing technology. Market: The veterinary diagnostics market is hungry for innovation and has low regulatory barriers. This market is estimated at €4 billion, with an 8.6% expected growth for the period 2016 to 2021. Magnomics will focus on the detection of bovine mastitis - an inflammation of the dairy cow’s mammary gland, whose treatment depends on the bacteria involved. This ailment causes over €30 billion in annual losses for producers worldwide. In the initial target markets (North America, Europe and Brazil), there are 56 million dairy cows with an average mastitis base incidence 30%. Given a €25 price tag and some segmentation, this amounts to a serviceable market of close to €300M, in which a penetration of 10-15% is expectable. The product can be sold either directly to farmers or to veterinarians: strategic partnerships are being negotiated with large pharma/dairy players to ensure market access.Competition: Companies such as AAD, DeLaval, and PortaCheck already have on-site solutions, which include California Mastitis Tests (CMT), Somatic Cell Counters and variants (SCC), as well as lateral flow strips. These current on-site diagnostics tools indicate the presence of an infection but are unable to determine the pathogen, which is key to define an appropriate treatment. Culture testing (e.g. Idexx, Virbac) is the current benchmark and is being tried on site as well: although cheap, the added value is greatly diminished due to long waiting times and difficulties in setting up a working protocol. Finally, laboratories provide fast molecular solutions (e.g. ThermoFisher) that are fast but expensive, while requiring complicated logistics due to sample collection that increase lead times. Magnomics will bring these molecular solutions to the farm in a convenient and affordable product.

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Investment focus

Health Care, Medical Device, Medical
Grant, Pre-Seed, Seed
United Kingdom, Spain, Ireland

Portfolio highlights

Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
Trak — Do you know TRAK's tele rehabilitation software? Get more clinical performance and grow your physical therapy business, request a trial!
Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.

Boule develops, manufactures, and markets hematology analyzers for both human and veterinary markets. Read more about us here.

Investment focus

Medical, Health Care, Medical Device
Series A
Portugal

Portfolio highlights

Biosurfit — At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.